4.6 Editorial Material

Application of Machine Learning in Drug Development and Regulation: Current Status and Future Potential

Journal

CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 107, Issue 4, Pages 726-729

Publisher

WILEY
DOI: 10.1002/cpt.1771

Keywords

-

Ask authors/readers for more resources

Machine learning (ML), a field of data science with over 50 years of history, has gained momentum in the past decade due to the intersection of powerful computing tools and the increased availability of large data sets. Herein, we provide an overview of a sample of ML algorithms and describe areas where ML has been used to support drug development and regulatory submissions to the US Food and Drug Administration (FDA), as well as to facilitate review and research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available